Entry mechanisms used by a model retrovirus
模型逆转录病毒使用的进入机制
基本信息
- 批准号:8577613
- 负责人:
- 金额:$ 36.66万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-09-15 至 2018-04-30
- 项目状态:已结题
- 来源:
- 关键词:AcidsAddressAntiviral AgentsAvian Leukosis VirusAvian SarcomaBindingBiological AssayBiological ModelsCapsidCell membraneCell physiologyCellsCellular MembraneCholesterolCuesCytoplasmDataDependenceDepositionDetectionDynaminEarly EndosomeEbola virusElectron MicroscopyEmployee StrikesEndocytosisEndosomesEventExposure toFutureGenomeGenus AlpharetrovirusGlycoproteinsGoalsGrowthHIVHIV-1Hepatitis C virusHuman VirusImageImageryImaging TechniquesIn SituInfectionIntegration Host FactorsKineticsKnowledgeLaboratoriesLifeLightLipid BilayersLipidsLiposomesMeasurementMediatingMembraneMembrane FusionMethodologyModelingMolecularMonitorNatureNucleocapsidOutcomePathway interactionsPlayPositioning AttributeProcessReactionRegulationReportingRetroviridaeRoleSiteStimulusTechniquesTemperatureTestingTherapeuticTimeViralViral GenomeViral ProteinsVirusWorkbasebis(monoacylglyceryl)phosphatecell typecellular imagingdesigninsightlate endosomelight microscopynovelnovel strategiesparticlepreferencepublic health relevancereceptorresponsetooluptake
项目摘要
DESCRIPTION (provided by applicant): Enveloped viruses release their nucleocapsids into the cytoplasm by merging their membrane with the cell membrane. The majority of these viruses is internalized by cells and fuses with endosomes. The elucidation of the molecular mechanisms of virus-endosome fusion and its regulation has been hampered by the highly dynamic nature of endosomes and the lack of access to these compartments. We have developed non- invasive imaging techniques that permit the time-resolved visualization of the critical steps of virus entry, from hemifusion (lipid transfer), to small pore formation (release o small content markers) and pore enlargement (release of the capsid). The recently implemented imaging assay enables (i) measurements of the pH in virus- carrying endosomes and (ii) detection of the resulting fusion events. We propose to apply these imaging and other approaches to define the mechanism of entry of the Avian Sarcoma and Leukosis Virus (ASLV), which is an excellent model for elucidating the entry pathways used by disparate viruses. The two-step triggering of ASLV-endosome fusion - binding to a cognate receptor and exposure to low pH - permit an unprecedented control over the virus entry process. Our pilot data suggest that, strikingly, the ASLV fusion with early acidic endosomes is restricted in some cell types and occurs in late endosomal compartments. These findings imply that ASLV fusion is regulated by cellular factors and that this virus may undergo hemifusion or form a small fusion pore in early endosomes, while relying on host factors to drive the energetically unfavorable step of pore enlargement. To test this hypothesis, we will: (1) investigate the spatio-temporal regulation of ASLV fusion; (2) examine the determinants of ASLV pore enlargement; and (3) define the role of endosomal lipids in ASLV fusion. These studies will provide critical insights into the ASLV fusion and its regulation by host factors. Knowledge of the mechanisms of ASLV fusion will offer a conceptual framework for studies of human viruses, such as HIV-1, Hepatitis C virus and Ebola virus, which enter host cells via the endocytic pathway and rely on a multitude of host factors.
描述(由申请人提供):包膜病毒通过将其膜与细胞膜结合,将其核衣壳释放到细胞质中。这些病毒大多数被细胞内化并与核内体融合。病毒-核内体融合及其调控的分子机制的阐明一直受到核内体的高度动态性和缺乏进入这些区室的途径的阻碍。我们已经开发了非侵入性成像技术,允许对病毒进入的关键步骤进行时间分辨可视化,从半灌注(脂质转移)到小孔形成(释放小含量标记物)和孔扩大(释放衣壳)。最近实施的成像分析能够(i)测量携带病毒的核内体的pH值和(ii)检测产生的融合事件。我们建议应用这些成像和其他方法来定义禽肉瘤和白血病病毒(ASLV)的进入机制,这是阐明不同病毒使用的进入途径的一个很好的模型。aslv -核内体融合的两步触发——与同源受体结合和暴露于低pH——允许对病毒进入过程进行前所未有的控制。我们的试点数据表明,引人注目的是,ASLV与早期酸性内体的融合在某些细胞类型中受到限制,并发生在晚期内体室中。这些发现表明,ASLV融合受细胞因子的调控,该病毒可能在早期核内体中经历半融合或形成小融合孔,同时依赖宿主因子驱动孔扩大这一能量上不利的步骤。为了验证这一假设,我们将:(1)研究ASLV融合的时空调节;(2)研究ASLV孔隙扩大的决定因素;(3)明确内体脂质在ASLV融合中的作用。这些研究将为ASLV融合及其受宿主因子的调控提供重要的见解。了解ASLV融合机制将为研究人类病毒(如HIV-1、丙型肝炎病毒和埃博拉病毒)提供一个概念框架,这些病毒通过内吞途径进入宿主细胞,依赖于多种宿主因子。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Gregory B Melikian其他文献
Gregory B Melikian的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Gregory B Melikian', 18)}}的其他基金
Molecular Interactions of HIV-1 with the Nuclear Pore Complex
HIV-1 与核孔复合物的分子相互作用
- 批准号:
10241258 - 财政年份:2019
- 资助金额:
$ 36.66万 - 项目类别:
Molecular Interactions of HIV-1 with the Nuclear Pore Complex
HIV-1 与核孔复合物的分子相互作用
- 批准号:
10462620 - 财政年份:2019
- 资助金额:
$ 36.66万 - 项目类别:
Inhibition of viral entry by interferon-induced proteins
干扰素诱导蛋白抑制病毒进入
- 批准号:
10418696 - 财政年份:2018
- 资助金额:
$ 36.66万 - 项目类别:
Inhibition of viral entry by interferon-induced proteins
干扰素诱导蛋白抑制病毒进入
- 批准号:
10190798 - 财政年份:2018
- 资助金额:
$ 36.66万 - 项目类别:
Imaging of Single HIV-1 Uncoating and Transport to the nucleus
单个 HIV-1 脱壳和转运至细胞核的成像
- 批准号:
9354023 - 财政年份:2017
- 资助金额:
$ 36.66万 - 项目类别:
Functional Characterization of the Hepatitis C Virus E1-E2 Glycoproteins
丙型肝炎病毒 E1-E2 糖蛋白的功能表征
- 批准号:
7522862 - 财政年份:2009
- 资助金额:
$ 36.66万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 36.66万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 36.66万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 36.66万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 36.66万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 36.66万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 36.66万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 36.66万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 36.66万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 36.66万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 36.66万 - 项目类别:
Research Grant